Vigil Neuroscience

About:

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Twitter/X: VigilNeuro

Top Investors: Sanofi, OrbiMed, Alexandria Venture Investments, Cormorant Asset Management, Invus

Description:

Vigil will use the Series A funds to progress its lead pipeline candidate, a monoclonal antibody TREM2 agonist, through Phase 1 studies, advance their small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.

Total Funding Amount:

$180M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)vigilneuro.com

Founders:

Ivana Magovčević-Liebisch

Number of Employees:

51-100

Last Funding Date:

2024-06-27

IPO Status:

Public

Industries: